Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Taspoglutide

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Taspoglutide?

Taspoglutide is an investigational drug.

There have been 13 clinical trials for Taspoglutide. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2008.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Cardiovascular Diseases. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].

Recent Clinical Trials for Taspoglutide
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular DiseaseHoffmann-La RochePhase 3
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination TherapyHoffmann-La RochePhase 3
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 DiabetesHoffmann-La RochePhase 3

See all Taspoglutide clinical trials

Clinical Trial Summary for Taspoglutide

Top disease conditions for Taspoglutide
Top clinical trial sponsors for Taspoglutide

See all Taspoglutide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.